Inflammatory bowel diseases (IBD), comprising Crohn's disease and ulcerative colitis, are systemic and multifaceted disorders which affect other organs in addition to the gastrointestinal tract in up to 50% of cases. Extraintestinal manifestations may present before or after IBD diagnosis and negatively impact the intestinal disease course and patients' quality of life, often requiring additional diagnostic evaluations or specific treatments. Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. Current evidence shows an increased prevalence of NAFLD (and its more advanced stages, such as liver fibrosis and steatohepatitis) in IBD patients compared to the general population. Many different IBD-specific etiopathogenetic mechanisms have been hypothesized, including chronic inflammation, malabsorption, previous surgical interventions, changes in fecal microbiota, and drugs. However, the pathophysiological link between these two diseases is still poorly understood. In this review, we aim to provide a comprehensive overview of the potential mechanisms which have been investigated so far and highlight open issues still to be addressed for future studies.

Maresca, R., Mignini, I., Varca, S., Calvez, V., Termite, F., Esposto, G., Laterza, L., Scaldaferri, F., Ainora, M. E., Gasbarrini, A., Zocco, M. A., (Abstract) Inflammatory Bowel Diseases and Non-Alcoholic Fatty Liver Disease: Piecing a Complex Puzzle Together, <<INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES>>, N/A; 25 (6): N/A-N/A. [doi:10.3390/ijms25063278] [https://hdl.handle.net/10807/277646]

Inflammatory Bowel Diseases and Non-Alcoholic Fatty Liver Disease: Piecing a Complex Puzzle Together

Maresca, Rossella;Mignini, Irene;Varca, Simone;Calvez, Valentin;Termite, Fabrizio;Esposto, Giorgio;Laterza, Lucrezia;Scaldaferri, Franco;Ainora, Maria Elena;Gasbarrini, Antonio;Zocco, Maria Assunta
2024

Abstract

Inflammatory bowel diseases (IBD), comprising Crohn's disease and ulcerative colitis, are systemic and multifaceted disorders which affect other organs in addition to the gastrointestinal tract in up to 50% of cases. Extraintestinal manifestations may present before or after IBD diagnosis and negatively impact the intestinal disease course and patients' quality of life, often requiring additional diagnostic evaluations or specific treatments. Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. Current evidence shows an increased prevalence of NAFLD (and its more advanced stages, such as liver fibrosis and steatohepatitis) in IBD patients compared to the general population. Many different IBD-specific etiopathogenetic mechanisms have been hypothesized, including chronic inflammation, malabsorption, previous surgical interventions, changes in fecal microbiota, and drugs. However, the pathophysiological link between these two diseases is still poorly understood. In this review, we aim to provide a comprehensive overview of the potential mechanisms which have been investigated so far and highlight open issues still to be addressed for future studies.
2024
Inglese
Maresca, R., Mignini, I., Varca, S., Calvez, V., Termite, F., Esposto, G., Laterza, L., Scaldaferri, F., Ainora, M. E., Gasbarrini, A., Zocco, M. A., (Abstract) Inflammatory Bowel Diseases and Non-Alcoholic Fatty Liver Disease: Piecing a Complex Puzzle Together, <<INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES>>, N/A; 25 (6): N/A-N/A. [doi:10.3390/ijms25063278] [https://hdl.handle.net/10807/277646]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/277646
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact